Laboratorios Liomont
Mexico City, Mexico· Est.
Mexican‑owned pharma producing generics, biosimilars and vaccines for global markets.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Mexican‑owned pharma producing generics, biosimilars and vaccines for global markets.
CardiovascularInfectious DiseasesOncologyImmunologyVaccinesGeneral Medicine
Technology Platform
Recombinant DNA and aseptic manufacturing for biologics, coupled with advanced formulation and GMP‑compliant sterile production lines for generics and biosimilars.
Opportunities
Expansion of biosimilar and vaccine portfolios in emerging markets and strategic collaborations for technology transfer.
Risk Factors
Regulatory hurdles, competition from global biologics players, and financing needs for sustained R&D.
Competitive Landscape
Competes with Mexican generic manufacturers and international biosimilar firms; differentiation lies in integrated biotech capabilities and export network.